Phase 3 Readout~month

Phase 3 Topline: A Phase II/III ,Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Adaptive

Indication
Depressive Disorder, Major

Other upcoming events for SBFM

Phase 1 StartPhase 1 Start: The Drug-Drug Interaction Study of Clifutinib
Phase 3 ReadoutPhase 3 Topline: A Phase II/III ,Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Adaptive
Phase 3 ReadoutPhase 3 Topline: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Efficacy and Safet
Phase 3 ReadoutPhase 3 Topline: HEC73543 Versus Salvage Chemotherapy in Relapsed or Refractory FLT3-ITD Acute Myeloid Leukemia: a Mu
Phase 3 ReadoutPhase 3 Topline: HEC73543 Versus Salvage Chemotherapy in Relapsed or Refractory FLT3-ITD Acute Myeloid Leukemia: a Mu

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase II/III ,Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Adaptive — SBFM Phase 3 Readout | BioSniper